Analysis

ImmunityBio has entered February with significant operational momentum, driven by surging revenue, greater clarity from U.S. regulators, and initial international...

The stock of T1 Energy is navigating a period of extreme volatility and contradictory pressures. Despite achieving a new 52-week...

As MercadoLibre prepares to unveil its fourth-quarter 2025 financial results, a significant legal battle in Argentina has reached a critical...

Investor attention is fixed on OMV as the Austrian energy group prepares to release its full-year 2025 results this Wednesday....

Defense contractor Lockheed Martin is significantly accelerating output of its missile defense systems. A newly finalized agreement with the U.S....

The company that became a household name during the global health crisis is now executing a deliberate and fundamental strategic...

Beyond Meat begins the week under a cloud of legal uncertainty. A wave of class-action lawsuits now overshadows the company's...

All eyes are on Fiserv as the financial technology giant prepares to release its fourth-quarter 2025 results on February 10....

Netflix has closed its 2025 fiscal year with robust performance, setting a confident tone for the period ahead. As its...

All eyes are on Monster Beverage as it prepares to release its financial performance figures for the final period of...